Valitor SideBySide.png
Valitor Announces Presentation on Novel Anti-VEGF Antibody Conjugate and Multivalent Polymer Technology Platform at Upcoming Ophthalmology Innovation Source (OIS) Summit
December 01, 2022 16:00 ET | Valitor, Inc.
BERKELEY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that its president and chief scientific...
Valitor SideBySide.png
Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer
October 05, 2022 08:00 ET | Valitor, Inc.
BERKELEY, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that it has closed a Series B...